| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
glutathione peroxidase 1 | 0.458 | 0.923 | 3.9E-05 |
|
group | 0.350 | None | 1.000 | 1 | 0 | 1994 | 2008 | ||||||||
|
mitogen-activated protein kinase 14 | 0.379 | 0.923 | 0.37 |
|
group | 0.350 | None | 1.000 | 1 | 0 | 2003 | 2019 | ||||||||
|
erb-b2 receptor tyrosine kinase 3 | 0.448 | 0.808 | 1.7E-15 |
|
group | 0.350 | None | 1.000 | 1 | 0 | 2002 | 2015 | ||||||||
|
cytochrome P450 family 2 subfamily A member 6 | 0.556 | 0.731 | 5.4E-09 |
|
group | 0.340 | None | 1.000 | 6 | 0 | 1999 | 2015 | ||||||||
|
cyclin dependent kinase inhibitor 1A | 0.403 | 0.769 | 1.9E-03 |
|
group | 0.340 | None | 1.000 | 2 | 0 | 2002 | 2014 | ||||||||
|
mitogen-activated protein kinase 3 | 0.379 | 0.885 | 3.7E-02 |
|
group | 0.340 | None | 1.000 | 2 | 0 | 2002 | 2018 | ||||||||
|
tumor protein p73 | 0.449 | 0.808 | 1.00 |
|
group | 0.340 | None | 1.000 | 1 | 0 | 2003 | 2017 | ||||||||
|
cancer susceptibility 1 | 0.760 | 0.269 | 3.9E-14 |
|
group | 0.340 | None | 1.000 | 1 | 0 | 2003 | 2014 | ||||||||
|
cytochrome P450 family 1 subfamily B member 1 | 0.457 | 0.769 | 2.2E-05 |
|
group | 0.340 | None | 1.000 | 1 | 0 | 2001 | 2017 | ||||||||
|
cytochrome P450 family 24 subfamily A member 1 | 0.518 | 0.692 | 3.2E-23 |
|
group | 0.340 | None | 1.000 | 1 | 0 | 2006 | 2017 | ||||||||
|
interferon gamma | 0.288 | 0.962 | 0.47 |
|
group | 0.340 | None | 1.000 | 1 | 0 | 1995 | 2019 | ||||||||
|
CLPTM1 like | 0.551 | 0.654 | 4.4E-05 |
|
group | 0.330 | None | 1.000 | 3 | 0 | 2008 | 2014 | ||||||||
|
cytochrome P450 family 2 subfamily E member 1 | 0.459 | 0.885 | 8.1E-09 |
|
group | 0.330 | None | 1.000 | 2 | 0 | 1991 | 2009 | ||||||||
|
interleukin 1 beta | 0.276 | 0.962 | 0.13 |
|
group | 0.330 | None | 1.000 | 2 | 0 | 2004 | 2017 | ||||||||
|
transthyretin | 0.423 | 0.885 | 0.52 |
|
group | 0.330 | None | 1.000 | 2 | 0 | 2007 | 2019 | ||||||||
|
MCL1 apoptosis regulator, BCL2 family member | 0.430 | 0.808 | 0.96 |
|
group | 0.330 | None | 1.000 | 2 | 0 | 2005 | 2017 | ||||||||
|
thymidylate synthetase | 0.425 | 0.846 | 0.72 |
|
group | 0.330 | None | 1.000 | 2 | 0 | 2003 | 2017 | ||||||||
|
BCL2 like 1 | 0.493 | 0.885 | 0.94 |
|
group | 0.330 | None | 1.000 | 1 | 0 | 2005 | 2013 | ||||||||
|
prostaglandin I2 synthase | 0.617 | 0.654 | 1.2E-09 |
|
group | 0.330 | None | 0.500 | 1 | 0 | 2002 | 2018 | ||||||||
|
methylenetetrahydrofolate reductase | 0.337 | 0.885 | 3.2E-10 |
|
group | 0.330 | None | 1.000 | 1 | 0 | 2005 | 2008 | ||||||||
|
matrix metallopeptidase 10 | 0.553 | 0.808 | 5.9E-15 |
|
group | 0.330 | None | 0.667 | 1 | 0 | 2004 | 2012 | ||||||||
|
cholinergic receptor nicotinic alpha 5 subunit | 0.593 | 0.577 | 2.1E-06 |
|
group | 0.330 | None | 1.000 | 1 | 0 | 2008 | 2008 | ||||||||
|
microRNA 21 | 0.363 | 0.846 |
|
group | 0.330 | None | 1.000 | 1 | 0 | 2011 | 2018 | |||||||||
|
Raf-1 proto-oncogene, serine/threonine kinase | 0.418 | 0.885 | 0.85 |
|
group | 0.330 | None | 1.000 | 1 | 0 | 2002 | 2016 | ||||||||
|
DNA methyltransferase 3 alpha | 0.445 | 0.846 | 7.4E-39 |
|
group | 0.330 | None | 1.000 | 1 | 0 | 2007 | 2015 |